I. Overview of the Peptide Drug Industry Peptide drugs are specific applications of peptides in the pharmaceutical sector, mainly manufactured via chemical synthesis, genetic recombination, or extraction from animals and plants. With molecular weights ranging from 500 to 10,000, they fall between small‑molecule chemical drugs and protein therapeutics, combining features of both. Peptide drugs feature […]

Widely adopted in diabetes, weight loss, chronic kidney disease and other chronic diseases, GLP‑1‑based peptides fuel rapid expansion of the global peptide drug market. Per Sullivan forecasts, the market will grow from $60.7 billion (2018) to $261.2 billion (2032). Patent expirations of major peptide drugs during 2014‑2026 boost generic development, pushing pharmaceutical companies to advance […]

Editor’s Note: Peptide drugs have emerged as vital therapies for various diseases and boomed over the past two decades. Since 2025, major breakthroughs have been achieved in metabolic diseases and other fields. WuXi TIDES, an integrated CRDMO platform under WuXi AppTec, provides end‑to‑end peptide synthesis services to accelerate innovative therapies to market. This article reviews […]

The ICIC 2026 International Cosmetic Innovation Conference concluded successfully! As the premier global event for beauty research and industrial innovation, the conference brought together leading suppliers, top-tier research institutions, authoritative dermatology experts, and mainstream brands to focus on core topics such as cosmetic technology innovation, efficacy-driven skincare, and precision anti-aging, fostering discussions on the future […]

From April 21 to 23, CPHI Japan 2026 was grandly held in Tokyo, Japan. As a flagship event in the pharmaceutical industry across Asia and globally, this exhibition brought together over 800 premium exhibitors from more than 70 countries and regions worldwide, attracting over 35,000 professional visitors—including pharmaceutical experts, R&D leaders, procurement managers, and industry […]

On March 26, at the 5th Peptide Industry Innovation & Development Forum, the “Peptide Future” – 2025 China Peptide Drug Industry Innovation List, co‑launched by Changsha Luocheng Trading Co., Ltd. and E‑Pharm Academy, was officially released. Supported by PharmaDu Data, the list reviews 15‑year core industrial achievements (2010‑2025). Based on the forum’s evaluation system and […]